Featured in SCRS InSite Journal: Scott Gray, CEO, discusses patient recruitment and retention, two of the most pressing challenges facing clinical research today. Continue reading to learn more about understanding the financial, logistical, and emotional barriers to participation, the consequences of poor retention and enrollment, actionable steps to improve trial outcomes, and other key findings […]
voice of the patient
In this SCRS Talks podcast, Scott Gray, CEO, highlights statistics from an independent, IRB-approved survey of patients and caregivers regarding participation in clinical trials. Learn about the financial risks of patient dropouts and trial delays, plus practical strategies for making trial participation easier and encouraging patient retention.
Featured on CenterWatch.com: Newly published results from a survey, conducted by the patient support service company Clincierge, found that 95 percent of the trial participants responded and 98 percent of their caregivers considered it essential to have a single point of contact to help them throughout a trial, especially when arranging travel plans.
Featured on ACRPnet.org: Looking for ways to increase participation in your clinical trials? First, stop calling participants “subjects,” says Scott Gray, CEO of Clincierge, whose organization just released a research report, “Voice of the Patient,” examining the patient experience in clinical trials of rare diseases. “They are volunteers, they are human beings,” Gray says.
PHILADELPHIA and SAN DIEGO, June 14, 2022 /PRNewswire/ — Clincierge today released “Voice of the Patient,” a research report examining the patient experience in clinical trials of rare diseases, at the 2022 BIO International Convention in San Diego, California.
Featured in Drug Discovery World: DDW’s Reece Armstrong speaks to Scott Gray, President & CEO of Clincierge about its unique approach to improving the clinical trial experience for patients.
During BIO International, a group of industry experts discussed patient recruitment and retention challenges in the panel discussion Participant Sensitivity: Amplifying the Voice of the Patient in Clinical Trials on Monday, June 13. Outsourcing-Pharma spoke with Clincierge CEO Scott Gray, the moderator of the talk, to get a sneak peek at the session.
Featured in The Science Advisory Board: Patient recruitment and retention are among the biggest challenges facing clinical research, particularly in studies targeting rare diseases that have a limited pool of patients, contends Clincierge CEO Scott Gray. At the 2022 Biotechnology Innovation Organization (BIO) International Convention, Clincierge will release the results of an independent, institutional review
PHILADELPHIA, June 2, 2022 /PRNewswire/ — Clincierge today announced CEO Scott Gray will moderate Participant Sensitivity: Amplifying the Voice of the Patient in Clinical Trials at the upcoming 2022 BIO International Convention on June 13-16, 2022, in San Diego, California.
Emotions of fear and uncertainty often flood an individual when they first receive a rare disease diagnosis. Many patients will require assistance with daily tasks and transportation and logistics involved in various doctor’s appointments, treatment methods, and at times, participation in a clinical trial. Patients reach out to family and friends who act as caregivers,